Search
for
Sort by
Research 361–390 of 1000+
- Genetic analysis of the role of androgen metabolism in the pathogenesis of prostate cancer
- Certain Cancer Myths Endure, with Impact on Treatment, Prevention, Screening
- Oral contraceptives and risk of breast cancer in women aged 20–54 years
- Exploring the historical stigma of spironolactone use in breast cancer survivors with alopecia
- Prostate cancer and androgenic alopecia: The role of finasteride as a dual agent
- 341 ANDROGENETIC ALOPECIA AT VARIOUS AGES AND PROSTATE CANCER RISK IN AN EQUAL ACCESS MULTIETHNIC CASE CONTROL SERIES OF VETERANS
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
- Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome
- Tracing the cellular origin of cancer
- Epigenetics of Colorectal Cancer
- Selenium for preventing cancer
- Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt
- Nonmelanoma skin cancer treated with electronic brachytherapy: Results at 1 year
- Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women’s cancers. Results of a prospective study
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Frequent downregulation of DMBT1 and galectin‐3 in epithelial skin cancer
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer
- Redefining hormone resistance in prostate cancer
- Pre‐clinical evidences for the efficacy of tryptanthrin as a potent suppressor of skin cancer
- Curcumin and cancer biology: Focusing regulatory effects in different signalling pathways
- Androgenetic alopecia and prostate cancer: findings from an Australian case-control study.
- Repurposing Kir6/SUR2 Channel Activator Minoxidil to Arrests Growth of Gynecologic Cancers
- Premature aging and cancer development in transgenic mice lacking functional CYLD
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus